- Home
- BFST vs IRMD Comparison
BFST vs IRMD Comparison
Compare BFST & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFST | IRMD |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BFST | IRMD |
|---|---|---|
| Price | $31.44 | $86.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $32.75 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 179.3K | 83.4K |
| Earning Date | 04-27-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.23% | 0.95% |
| EPS Growth | ★ 23.45 | 16.67 |
| EPS | ★ 1.37 | 0.86 |
| Revenue | $10,704,000.00 | ★ $83,814,000.00 |
| Revenue This Year | $22.71 | $12.38 |
| Revenue Next Year | $5.02 | $11.31 |
| P/E Ratio | ★ $22.85 | $100.20 |
| Revenue Growth | 1.20 | ★ 14.43 |
| 52 Week Low | $22.56 | $67.84 |
| 52 Week High | $32.53 | $107.90 |
Technical Indicators
Market Signals| Indicator | BFST | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 36.69 |
| Support Level | $31.26 | $84.05 |
| Resistance Level | $32.46 | $88.93 |
| Average True Range (ATR) | 0.47 | 1.99 |
| MACD | -0.07 | 0.08 |
| Stochastic Oscillator | 55.27 | 24.48 |
Price Performance
Historical ComparisonAbout BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.